医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease.

广告
第一作者: Ganesha,Liyanage
第一单位: Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, New South Wales, Australia.;School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
作者单位: Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, New South Wales, Australia.;School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. [1] Translational Neuroimmunology Group, Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, New South Wales, Australia.;Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. [2] Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, New South Wales, Australia. [3] Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, New South Wales, Australia.;Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. [4] Centre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, The University of Western Australia, Sir Charles Gairdner Hospital, QEII Medical Centre, Nedlands, Western Australia, Australia.;Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Murdoch, Western Australia, Australia. [5] Centre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, The University of Western Australia, Sir Charles Gairdner Hospital, QEII Medical Centre, Nedlands, Western Australia, Australia. [6] Department of Neurology, Monash Health, Clayton, Victoria, Australia. [7] Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia. [8] Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia.;Department of Neurology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia. [9] Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro Inflammation, and Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle, Hôpital Neurologique Pierre Wertheimer and Centre des Neurosciences de Lyon, INSERM 1028 et CNRS UMR5292, Lyon, France.;Université Claude Bernard Lyon 1, Lyon, France. [10] Multiple Sclerosis and Neuroimmunology Research Groups, Department of Neuroscience, Monash University, Clayton, Victoria, Australia. [11] Department of Neurology, John Hunter Hospital, Newcastle, New South Wales, Australia.;Hunter Medical Research Institute, The University of Newcastle, New Lambton Heights, New South Wales, Australia.;School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia. [12] Centre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, The University of Western Australia, Sir Charles Gairdner Hospital, QEII Medical Centre, Nedlands, Western Australia, Australia.;Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia. [13] Clinical Outcomes Research Unit (CORe), Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.;Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia. [14] School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia.;Department of Neurology, Gold Coast University Hospital, Southport, Queensland, Australia. [15] Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.;Clinical Neuroimmunology Group, Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, New South Wales, Australia. [16] Translational Neuroimmunology Group, Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, New South Wales, Australia.;Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.;Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia.;Department of Neurology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia. [17] Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children's Hospital at Westmead, Sydney, New South Wales, Australia fabienne.brilot@sydney.edu.au.;School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.;Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia. [18]
DOI 10.1136/jnnp-2023-332851
PMID 38290838
发布时间 2026-01-27
提交
  • 浏览3
Journal of neurology, neurosurgery, and psychiatry

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷